Point72 Asia (Singapore) Pte. Ltd. Chimerix Inc Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Chimerix Inc stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 36,907 shares of CMRX stock, worth $31,001. This represents 0.01% of its overall portfolio holdings.
Number of Shares
36,907Holding current value
$31,001% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CMRX
# of Institutions
80Shares Held
29.6MCall Options Held
18.9KPut Options Held
40.9K-
Monaco Asset Management Sam4.38MShares$3.68 Million1.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$3.65 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.26MShares$1.9 Million0.03% of portfolio
-
Acadian Asset Management LLC Boston, MA2.17MShares$1.83 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.9MShares$1.59 Million0.0% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $73.6M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...